INIFY Laboratories AB
OSE:INIFY
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.26
7.3
|
| Price Target |
|
We'll email you a reminder when the closing price reaches NOK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| SE |
I
|
INIFY Laboratories AB
OSE:INIFY
|
284m NOK |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
101.7B USD |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
72.3B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
62B EUR |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.5B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
21.3B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.5B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21B USD |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
14.4B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.4B EUR |
Loading...
|
|
| AU |
|
Sonic Healthcare Ltd
ASX:SHL
|
11.2B AUD |
Loading...
|
Market Distribution
| Min | -2 025 693.8% |
| 30th Percentile | -1.8% |
| Median | 6% |
| 70th Percentile | 12.5% |
| Max | 10 459.2% |
Other Profitability Ratios
INIFY Laboratories AB
Glance View
INIFY Laboratories AB engages in the provision of cancer diagnostics through laboratory services within pathology. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2022-06-20. The firm uses a fully digital, standardized and Artificial Intelligence (AI)- supported workflow to optimize quality and response times, initially within prostate. The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer’s organization. INIFY Laboratories' laboratory in Solna, Sweden is intended to provide two types of analyses of prostate Biopsy Specimens to clients: Full pathology Report signed by an INIFY subspecialized pathologist and Whole Slide Images (WSI) generation and result of Pathology Decision Support Tool (PDST) analysis only. The firm origins from ContextVision.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for INIFY Laboratories AB is -9 120.5%, which is above its 3-year median of -20 664.7%.
Over the last 5 months, INIFY Laboratories AB’s Operating Margin has increased from -31 097.3% to -9 120.5%. During this period, it reached a low of -31 097.3% on May 30, 2023 and a high of -10 232% on Oct 30, 2023.